Saniona AB (publ) (STO:SANION)

Sweden flag Sweden · Delayed Price · Currency is SEK
13.20
-0.30 (-2.22%)
Aug 29, 2025, 5:29 PM CET
-2.22%
Market Cap1.82B
Revenue (ttm)339.70M
Net Income (ttm)214.40M
Shares Out138.03M
EPS (ttm)1.82
PE Ratio7.24
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,991,280
Average Volume1,810,346
Open12.96
Previous Close13.50
Day's Range12.76 - 13.48
52-Week Range2.51 - 14.88
Beta0.87
RSI68.80
Earnings DateAug 28, 2025

About Saniona AB

Saniona AB (publ), a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels. The company’s product includes Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical trial to treat people with obesity; and Tesomet, an oral investigational therapy, which is in Phase 2b clinical trial for the treatment of hypothalamic ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 22
Stock Exchange Nasdaq Stockholm
Ticker Symbol SANION
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.